ATE190659T1 - Rekombinante immuntoxine - Google Patents
Rekombinante immuntoxineInfo
- Publication number
- ATE190659T1 ATE190659T1 AT92921866T AT92921866T ATE190659T1 AT E190659 T1 ATE190659 T1 AT E190659T1 AT 92921866 T AT92921866 T AT 92921866T AT 92921866 T AT92921866 T AT 92921866T AT E190659 T1 ATE190659 T1 AT E190659T1
- Authority
- AT
- Austria
- Prior art keywords
- recombinant
- immuntoxins
- relates
- immunotoxins
- pe38kdel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76733191A | 1991-09-30 | 1991-09-30 | |
| PCT/US1992/008257 WO1993007286A1 (en) | 1991-09-30 | 1992-09-29 | Recombinant immunotoxins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE190659T1 true ATE190659T1 (de) | 2000-04-15 |
Family
ID=25079156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92921866T ATE190659T1 (de) | 1991-09-30 | 1992-09-29 | Rekombinante immuntoxine |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0610286B1 (de) |
| JP (1) | JP3512795B2 (de) |
| AT (1) | ATE190659T1 (de) |
| AU (1) | AU675413B2 (de) |
| CA (1) | CA2120153C (de) |
| DE (1) | DE69230798T2 (de) |
| DK (1) | DK0610286T3 (de) |
| WO (1) | WO1993007286A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981726A (en) * | 1990-10-12 | 1999-11-09 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric and mutationally stabilized tumor-specific B1, B3 and B5 antibody fragments; immunotoxic fusion proteins; and uses thereof |
| US5889157A (en) * | 1990-10-12 | 1999-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Humanized B3 antibody fragments, fusion proteins, and uses thereof |
| US5608039A (en) * | 1990-10-12 | 1997-03-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Single chain B3 antibody fusion proteins and their uses |
| CA2128511C (en) * | 1992-01-23 | 2006-11-07 | Andreas Pluckthun | Monomeric and dimeric antibody-fragment fusion proteins |
| WO1994002610A1 (en) * | 1992-07-17 | 1994-02-03 | Dana-Farber Cancer Institute | Method of intracellular binding of target molecules |
| US5747654A (en) * | 1993-06-14 | 1998-05-05 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| FR2706486B1 (fr) * | 1993-06-16 | 1995-09-01 | Rhone Poulenc Rorer Sa | Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques. |
| US5851829A (en) * | 1993-07-16 | 1998-12-22 | Dana-Farber Cancer Institute | Method of intracellular binding of target molecules |
| AU717611B2 (en) * | 1994-10-28 | 2000-03-30 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Tumor-specific antibody fragments, fusion proteins, and uses thereof |
| AU5965296A (en) * | 1995-05-31 | 1996-12-18 | Regents Of The University Of Minnesota | Recombinant polypeptide cytotoxins for cancer treatment |
| US5980895A (en) * | 1995-10-13 | 1999-11-09 | The United States Of America As Represented By The Department Of Health And Human Services | Immunotoxin containing a disulfide-stabilized antibody fragment joined to a Pseudomonas exotoxin that does not require proteolytic activation |
| BR9710811A (pt) | 1996-05-22 | 1999-08-17 | Novopharm Biotech Inc | Fragmentos de liga-Æo de antigeno que detecta especificamente c-lulas cancerigenas nucleotideos que codificam os fragmentos e o seu uso para a profilaxia e detec-Æo de c-nceres |
| AU744873B2 (en) | 1996-11-06 | 2002-03-07 | Regents Of The University Of California, The | Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof |
| US7115722B1 (en) | 1997-05-22 | 2006-10-03 | Viventia Biotech, Inc. | Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| IL139705A0 (en) | 1998-05-20 | 2002-02-10 | Chugai Pharmaceutical Co Ltd | Novel method for gene cloning |
| US7030228B1 (en) | 1999-11-15 | 2006-04-18 | Miltenyi Biotec Gmbh | Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| WO2007071061A1 (en) * | 2005-12-23 | 2007-06-28 | Viventia Biotech Inc. | Methods for generating and screening fusion protein libraries and uses thereof |
| US8932586B2 (en) | 2011-09-06 | 2015-01-13 | Intrexon Corporation | Modified forms of Pseudomonas exotoxin A |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2053911C (en) * | 1989-04-21 | 1999-11-02 | Ira H. Pastan | Recombinant antibody-toxin fusion protein |
-
1992
- 1992-09-29 EP EP92921866A patent/EP0610286B1/de not_active Expired - Lifetime
- 1992-09-29 DE DE69230798T patent/DE69230798T2/de not_active Expired - Fee Related
- 1992-09-29 AU AU27798/92A patent/AU675413B2/en not_active Ceased
- 1992-09-29 WO PCT/US1992/008257 patent/WO1993007286A1/en not_active Ceased
- 1992-09-29 CA CA002120153A patent/CA2120153C/en not_active Expired - Fee Related
- 1992-09-29 DK DK92921866T patent/DK0610286T3/da active
- 1992-09-29 AT AT92921866T patent/ATE190659T1/de not_active IP Right Cessation
- 1992-09-29 JP JP50699493A patent/JP3512795B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2120153A1 (en) | 1993-04-15 |
| JPH07502643A (ja) | 1995-03-23 |
| DE69230798T2 (de) | 2000-08-03 |
| DE69230798D1 (de) | 2000-04-20 |
| EP0610286A4 (en) | 1995-10-25 |
| AU2779892A (en) | 1993-05-03 |
| WO1993007286A1 (en) | 1993-04-15 |
| EP0610286A1 (de) | 1994-08-17 |
| DK0610286T3 (da) | 2000-07-17 |
| JP3512795B2 (ja) | 2004-03-31 |
| CA2120153C (en) | 2006-06-06 |
| AU675413B2 (en) | 1997-02-06 |
| EP0610286B1 (de) | 2000-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69230798D1 (de) | Rekombinante immuntoxine | |
| GR3026658T3 (en) | Hydrazino-type radionuclide chelators having an n 3?s configuration | |
| FI844510L (fi) | Ensym-resistenta immunsystemet modulerande peptider. | |
| BR0112111A (pt) | Realce de respostas imunes mediadas por proteìna de fusão de anticorpo-citocina por tratamento combinado com agentes de realce de captação de imunocitocina | |
| ES8602768A1 (es) | Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas. | |
| FI951138A7 (fi) | Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa | |
| DE122006000010I2 (de) | Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in derBehandlung von kardiovaskularen Krankheiten | |
| FI73995B (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla 6,11-dihydro-dibenso-/b,e/-tiepin-11-n-alkyl- norskopinetrar. | |
| DK0668769T3 (da) | Egebarkekstrakt-relaterede syntetiske sammensætninger og fremgangsmåde til deres anvendelse | |
| DE69131200D1 (en) | Herpes simplex virus vp16 impfstoffe | |
| GR3026219T3 (en) | Mouse monoclonal antibodies | |
| DE69434384D1 (de) | Metalkomplexbildner | |
| ATE199167T1 (de) | Nichtglykosyliertes fgf-4 und dieses enthaltende präparate | |
| PT2314699T (pt) | Preparações médicas para o tratamento de deficiência em α-galactosidase a | |
| DK0563085T3 (da) | Hidtil ukendte præparater | |
| DE69106361D1 (de) | Einschlusskomplex von nimesulide mit cyclodextrinen. | |
| KR890700353A (ko) | 면역독소의 면역억제 기저 사람치료법 | |
| EP0311616A4 (de) | Kombination von gammainterferonen und antientzündungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten. | |
| BG101126A (en) | The use of muramylpeptide compounds | |
| DK1040191T3 (da) | RANTES-mutanter og terapeutiske anvendelser heraf | |
| DE69321585D1 (de) | PArENTERALE LÖSUNGEN ENTHALTEND 3-DIALKYLAMINOETHOXYBENZOYLBENZOFURANE | |
| ATE165594T1 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
| ATE130304T1 (de) | Neue alpha-glukosidaseinhibitoren. | |
| SE8900564D0 (sv) | Novel medicinal use | |
| FI933386A7 (fi) | Pienimolekyylisiä sulfatoituja poly-b-2,6-fruktofuranosaaneja ja niide n käyttö rappeuttavien nivelsairauksien hoitoon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |